![]() |
|||||||||||||
Beta Cell Biology Consortium (BCBC)Information excerpted from the BCBC website; additional information can be found there. BackgroundThe Beta Cell Biology Consortium (BCBC) is a team science initiative that was established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2001. Currently, the BCBC consists of 29 extramural scientists and scientists from two intramural NIDDK laboratories. The mission of the BCBC is to facilitate interdisciplinary approaches that will advance understanding of pancreatic islet development and function with the long-term goal of developing a cell-based therapy for insulin delivery. Mouse strains created within the consortium are made available for distribution after one year or following the characterization and initial peer-reviewed publication announcing their development, whichever comes first. They can be obtained from the MMRRC by investigators at academic institutions who want to make use of the resource for non-commercial research. MMRRC holdingsThe MMRRC holds over 15 strains in this collection. DistributionStrains are distributed using the MMRRC Conditions of Use *(COU). Mice are available only to investigators at not-for-profit institutions. Related Links |
MMRRC Contact Information
Home Page
The MMRRC is a collaborative effort, funded by grants from the National Center for Research Resources,
NIH, DHHS.
Web forms on this site assume JavaScript enabled for Netscape 6.x, Microsoft Internet Explorer 5.5 and later versions; forms will not function as expected with earlier versions or when JavaScript is turned off.
Last Modified: August 25, 2008